73619-26-8

Upstream product

• 64589-26-0 (+/-)-<(1,3/2,4,5)-5-acetamido-2,3,4-triacetoxycyclohexyl>-methyl acetate 
• 501-53-1 benzyl chloroformate 
• 32780-31-7 DL-validamine hydrochloride 

Downstream Products

• 86195-51-9 (-)-validamine hydrochloride 
• 32780-31-7 (+)-validamine hydrochloride 
• 73410-97-6 1D-2-O-β-D-glucopyranosyl-(1,3,4/2,6)-4-amino-6-hydroxymethyl-1,2,3-cyclohexanetriol 
• 73410-97-6 2-O-β-D-glucopyranosyl-1L-(1,3,4/2,6)-4-amino-6-hydroxymethyl-1,2,3-cyclohexanetriol 
• 73619-36-0 1D-1,7-O-benzylidene-3,4-N,O-carbonyl-2-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-(1,3,4/2,6)-4-amino-6-hydroxymethyl-1,2,3-cyclohexanetriol 
• 73619-36-0 1L-1,7-O-benzylidene-3,4-N,O-carbonyl-2-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-(1,3,4/2,6)-4-amino-6-hydroxymethyl-1,2,3-cyclohexanetriol 

Relevant academic research and scientific papers

SYNTHESIS OF β-D-GLUCOPYRANOSYLVALIDAMINE: 2-O-β-D-GLUCOPYRANOSYL-1L-(1,3,4/2,6)-4-AMINO-6-HYDROXYMETHYL-1,2,3-CYCLOHEXANETRIOL

β-D-Glucopyranosylvalidamine (1a), the structure of which was assigned to the degradation product of validamycin A, was synthesized by condensation of a protected validamine (8) with acetobromoglucose, followed by deblocking.Unexpectedly, 1a was found not to be identical with an authentic sample derived from the antibiotic